Albright Eric S MD is categorized under Family Practice Doctors in Denver, CO and active since 2005.
Albright Eric S MD was established in 2005, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Eric Albright at the company’s single location by writing to 850 East Harvard Avenue # 405, Denver, Colorado CO 80210 or by phoning (303) 722-4683. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Albright Eric S MD |
| Contact Person: | Eric Albright |
| Address: | 850 East Harvard Avenue # 405, Denver, Colorado 80210 |
| Phone Number: | (303) 722-4683 |
| Website Address: | endocrinology.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Albright Eric S MD was started in 2005 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Eric Albright for inquiries that concern Albright Eric S MD by calling the company number (303) 722-4683, as your correspondence is most welcome. Additionally, the physical location of the single location of Albright Eric S MD can be found at the coordinates 39.67124,-104.97795 as well as the street address 850 East Harvard Avenue # 405 in Denver, Colorado 80210.
For its online presence, you may visit Albright Eric S MD’s website at endocrinology.org and engage with its social media outlets through on Twitter and on Facebook.